The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Role for p38 Mitogen-activated Protein Kinase in Platelet Aggregation Caused by Collagen or a Thromboxane Analogue
Open accessAbstract
p38 mitogen-activated protein kinase (MAPK) was identified in platelets on the basis of (a) its reactivity with antibodies to C-terminal and N-terminal peptides, and (b) its ability to activate MAPK-activated protein kinase-2, which phosphorylates the small heat shock protein, hsp27. p38 MAPK was activated in platelets by collagen fibers, a collagen-related cross-linked peptide, thrombin, or the thromboxane analogue U46619. A highly specific inhibitor of p38 MAPK, a pyridinyl imidazole known as SB203580, inhibited the platelet enzyme in vitro (IC50 approximately 0.5 microM). At similar concentrations it also inhibited agonist-stimulated phosphorylation of hsp27 in platelets, and platelet aggregation and secretion induced by minimal aggregatory concentrations of collagen or U46619, but not thrombin. Inhibition of aggregation was overcome by increasing agonist dose. SB203580 might act by inhibiting thromboxane generation, but this was only inhibited by 10-20% at low agonist concentrations. p38 MAPK provides a crucial signal, which is necessary for aggregation caused by minimal concentrations of collagen fibers or U46619. Thrombin or high doses of these agonists generate signals that bypass the enzyme, or render the enzyme no longer rate-limiting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Self-citationA MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Self-citationThe stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T., & Nebreda, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90277-1 · Cited by 1,674
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
Cited by
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
The cellular thermal shift assay for evaluating drug target interactions in cells
Jafari, R., Almqvist, H., Axelsson, H., Ignatushchenko, M., Lundbäck, T., Nordlund, P., & Molina, D. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.138 · Cited by 1,474
Oxidative stress and gene regulation
Allen, R. G., & Tresini, M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00242-7 · Cited by 1,302
Dual specificity phosphatases: a gene family for control of MAP kinase function
CAMPS, M., NICHOLS, A., & ARKINSTALL, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.6 · Cited by 811
Guay, J., Lambert, H., Gingras-Breton, G., Lavoie, J. N., Huot, J., & Landry, J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.3.357 · Cited by 705
Knight, C. G., Morton, L. F., Peachey, A. R., Tuckwell, D. S., Farndale, R. W., & Barnes, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.35 · Cited by 695
Self-citationSARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Zhang, S., Liu, Y., Wang, X., Yang, L., Li, H., Wang, Y., Liu, M., Zhao, X., Xie, Y., Yang, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00954-7 · Cited by 657
Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site
Young, P. R., McLaughlin, M. M., Kumar, S., Kassis, S., Doyle, M. L., McNulty, D., Gallagher, T. F., Fisher, S., McDonnell, P. C., Carr, S. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12116 · Cited by 570
Self-citationThe search for physiological substrates of MAP and SAP kinases in mammalian cells
COHEN, P. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01105-7 · Cited by 536
Dean, J. L. E., Brook, M., Clark, A. R., & Saklatvala, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.264 · Cited by 492
Self-citationKramer, R. M., Roberts, E. F., Um, S. L., Börsch-Haubold, A. G., Watson, S. P., Fisher, M. J., & Jakubowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27723 · Cited by 481
Mahtani, K. R., Brook, M., Dean, J. L. E., Sully, G., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.6461-6469.2001 · Cited by 448
Self-citationThe p38 MAP kinase pathway as a therapeutic target in inflammatory disease
SAKLATVALA, J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.009 · Cited by 408
Self-citationProstanoids and prostanoid receptors in signal transduction
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.006 · Cited by 387
Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
Igarashi, M., Wakasaki, H., Takahara, N., Ishii, H., Jiang, Z.-Y., Yamauchi, T., Kuboki, K., Meier, M., Rhodes, C. J., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3326 · Cited by 386
“(66) also has reported that p38 MAP kinase may regulate platelet aggregation because SB-203580 can inhibit thromboxane generation.”
BackgroundLasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382
Self-citationMuda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., & Arkinstall, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27205 · Cited by 375
Cuenda, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.295 · Cited by 362
Schwarz, U. R., Walter, U., & Eigenthaler, M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00760-2 · Cited by 329
Growth Factors and Mitogen-Activated Protein Kinases
Force, T., & Bonventre, J. V. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.152 · Cited by 327
Stress-activated Protein Kinases: Activation, Regulation and Function
Paul, A., Wilson, S., Belham, C. M., Robinson, C. J. M., Scott, P. H., Gould, G. W., & Plevin, R. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(97)00042-9 · Cited by 321
Lu, L., Han, A.-P., & Chen, J.-J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.7971-7980.2001 · Cited by 315
Both Erk and p38 Kinases Are Necessary for Cytokine Gene Transcription
Carter, A. B., Monick, M. M., & Hunninghake, G. W. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3420 · Cited by 305
Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase
Nemoto, S., Xiang, J., Huang, S., & Lin, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16415 · Cited by 280
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., & Su, M. S. S. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90194-0 · Cited by 274
Crystal Structure of p38 Mitogen-activated Protein Kinase
Wilson, K. P., Fitzgibbon, M. J., Caron, P. R., Griffith, J. P., Chen, W., McCaffrey, P. G., Chambers, S. P., & Su, M. S.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27696 · Cited by 262
Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38
Lasa, M., Brook, M., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.771-780.2001 · Cited by 259
Self-citationDirect Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059
Börsch-Haubold, A. G., Pasquet, S., & Watson, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28766 · Cited by 255
Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism
Simmonds, R. E., Lali, F. V., Smallie, T., Small, P. L. C., & Foxwell, B. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802294 · Cited by 106
Metadata
- Authors
- Saklatvala, J., Rawlinson, L., Waller, R. J., Sarsfield, S., Lee, J. C., Morton, L. F., Barnes, M. J., & Farndale, R. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-03
- Volume
- 271
- Issue
- 12
- Pages
- 6586-6589
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2076309204
- Cited by
- 289
- References
- 22
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.